Regulatory T cells in rheumatoid arthritis

Arthritis Research and Therapy

Volumn 7, Issue 3, 2005, Pages 93-99

  Leipe, Jan ^a   Skapenko, Alla ^a   Lipsky, Peter E ^b   Schulze Koops, Hendrik ^a,b  

^a UNIVERSITY OF ERLANGEN NUREMBERG   (Germany)

^b NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD4 ANTIGEN; INTERLEUKIN 2 RECEPTOR ALPHA;

CELLULAR DISTRIBUTION; HUMAN; IMMUNE RESPONSE; IMMUNE SYSTEM; LYMPHOCYTE FUNCTION; LYMPHOCYTE PROLIFERATION; MOLECULAR MECHANICS; NONHUMAN; PHENOTYPE; REVIEW; RHEUMATOID ARTHRITIS; SUPPRESSOR CELL; SYNOVIOCYTE; T LYMPHOCYTE SUBPOPULATION;

ARTHRITIS, RHEUMATOID; CD4-POSITIVE T-LYMPHOCYTES; HUMANS; T-LYMPHOCYTES, REGULATORY;

EID: 20144376029     PISSN: 14786354     EISSN: None     Source Type: Journal    
DOI: 10.1186/ar1718     Document Type: Review

References (61)

1. Bach JF, Chatenoud L: Tolerance to islet autoantigens in type 1 diabetes. Annu Rev Immunol 2001, 19:131-161.
2. Ota K, Matsui M, Milford EL, Mackin GA, Weiner HL, Hafler DA: T-cell recognition of an immunodominant myelin basic protein epitope in multiple sclerosis. Nature 1990, 346:183-187.
3. Sakaguchi S: Regulatory T cells: key controllers of immunologic self-tolerance. Cell 2000, 101:455-458.
4. Gershon RK, Kondo K: Infectious immunological tolerance. Immunology 1971, 21:903-914.
5. Hedrick SM, Germain RN, Bevan MJ, Dorf M, Engel I, Fink P, Gascoigne N, Heber-Katz E, Kapp J, Kaufmann Y, et al.: Rearrangement and transcription of a T-cell receptor beta-chain gene in different T-cell subsets. Proc Natl Acad Sci USA 1985, 82:531-535.
6. Kronenberg M, Steinmetz M, Kobori J, Kraig E, Kapp JA, Pierce CW, Sorensen CM, Suzuki G, Tada T, Hood L: RNA transcripts for I-J polypeptides are apparently not encoded between the I-A and I-E subregions of the murine major histocompatibility complex. Proc Natl Acad Sci USA 1983, 80:5704-5708.
7. Janeway CA Jr: Do suppressor T cells exist? A reply. Scand J Immunol 1988, 27:621-623.
8. Sakaguchi S, Sakaguchi N, Asano M, Itoh M, Toda M: Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J Immunol 1995, 155:1151-1164.
9. McHugh RS, Shevach EM: Cutting edge: depletion of CD4+CD25+ regulatory T cells is necessary, but not sufficient, for induction of organ-specific autoimmune disease. J Immunol 2002, 168:5979-5983.
10. Mottet C, Uhlig HH, Powrie F: Cutting edge: cure of colitis by CD4+CD25+ regulatory T cells. J Immunol 2003, 170:3939-3943.
11. Miller JF, Basten A: Mechanisms of tolerance to self. Curr Opin Immunol 1996, 8:815-821.
12. Schwartz RH: Models of T cell energy: is there a common molecular mechanism? J Exp Med 1996, 184:1-8.
13. Miller JF, Heath WR: Self-ignorance in the peripheral T-cell pool. Immunol Rev 1993, 133:131-150.
14. Thornton AM, Shevach EM: Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J Immunol 2000, 164:183-190.
15. Takahashi T, Tagami T, Yamazaki S, Uede T, Shimizu J, Sakaguchi N, Mak TW, Sakaguchi S: Immunologic self-tolerance maintained by CD25+CD4+ regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J Exp Med 2000, 192:303-310.
16. Read S, Malmstrom V, Powrie F: Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25+CD4+ regulatory cells that control intestinal inflammation. J Exp Med 2000, 192:295-302.
17. McHugh RS, Whitters MJ, Piccirillo CA, Young DA, Shevach EM, Collins M, Byrne MC: CD4+CD25+ immunoregulatory T cells: gene expression analysis reveals a functional role for the glucocorticoid-induced TNF receptor. Immunity 2002, 16:311-323.
18. + regulatory T cells through GITR breaks immunological self-tolerance. Nat Immunol 2002, 3:135-142.
19. Huang CT, Workman CJ, Flies D, Pan X, Marson AL, Zhou G, Hipkiss EL, Ravi S, Kowalski J, Levitsky HI, et al.: Role of LAG-3 in regulatory T cells. Immunity 2004, 21:508-513.
20. Hori S, Nomura T, Sakaguchi S: Control of regulatory T cell development by the transcription factor Foxp3. Science 2003, 299:1057-1061.
21. Bennett CL, Christie J, Ramsdell F, Brunkow ME, Ferguson PJ, Whitesell L, Kelly TE, Saulsbury FT, Chance PF, Ochs HD: The immune dysregulation, polyendocrinopathy, enteropathy, X-linked syndrome (IPEX) is caused by mutations of FOXP3. Nat Genet 2001, 27:20-21.
22. Gambineri E, Torgerson TR, Ochs HD: Immune dysregulation, polyendocrinopathy, enteropathy, and X-linked inheritance (IPEX), a syndrome of systemic autoimmunity caused by mutations of FOXP3, a critical regulator of T-cell homeostasis. Curr Opin Rheumatol 2003, 15:430-435.
23. Baecher-Allan C, Hafler DA: Suppressor T cells in human diseases. J Exp Med 2004, 200:273-276.
24. + T cells: a highly differentiated and apoptosis-prone population. Eur J Immunol 2001, 31:1122-1131.
25. + T cells with regulatory properties isolated from peripheral blood. J Exp Med 2001, 193:1285-1294.
26. + T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J Exp Med 2001, 193:1295-1302.
27. + T cells with regulatory properties from human blood. J Exp Med 2001, 193:1303-1310.
28. Baecher-Allan C, Brown JA, Freeman GJ, Hafler DA: CD4+CD25high regulatory cells in human peripheral blood. J Immunol 2001, 167:1245-1253.
29. + thymocytes and peripheral T cells have immune suppressive activity in vitro. Eur J Immunol 2001, 31:1247-1254.
30. + human thymocytes. J Exp Med 2002, 196:379-387.
31. + regulatory T cells in rheumatoid arthritis: differences in the presence, phenotype, and function between peripheral blood and synovial fluid. Arthritis Rheum 2004, 50: 2775-2785.
32. Taams LS, Vukmanovic-Stejic M, Smith J, Dunne PJ, Fletcher JM, Plunkett FJ, Ebeling SB, Lombardi G, Rustin MH, Bijlsma JW, et al.: Antigen-specific T cell suppression by human CD4+CD25+ regulatory T cells. Eur J Immunol 2002, 32:1621-1630.
33. Woo EY, Yeh H, Chu CS, Schlienger K, Carroll RG, Riley JL, Kaiser LR, June CH: Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol 2002, 168:4272-4276.
34. Thornton AM, Shevach EM: CD4+CD25+ immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J Exp Med 1998, 188:287-296.
35. Weiner HL: Oral tolerance: immune mechanisms and the generation of Th3-type TGF-beta-secreting regulatory cells. Microbes Infect 2001, 3:947-954.
36. + regulatory T cells is mediated by cell surface-bound transforming growth factor beta. J Exp Med 2001, 194:629-644.
37. + regulatory T cells are enriched in inflamed joints of patients with chronic rheumatic disease. Arthritis Res Ther 2004, 6:R335-346.
38. Ehrenstein MR, Evans JG, Singh A, Moore S, Warnes G, Isenberg DA, Mauri C: Compromised function of regulatory T cells in rheumatoid arthritis and reversal by anti-TNFα therapy. J Exp Med 2004, 200:277-285.
39. + T cells from the target organ of patients with rheumatoid arthritis. Eur J Immunol 2003, 33:215-223.
40. de Kleer IM, Wedderburn LR, Taams LS, Patel A, Varsani H, Klein M, de Jager W, Pugayung G, Giannoni F, Rijkers G, et al.: CD4+CD25bright regulatory T cells actively regulate inflammation in the joints of patients with the remitting form of juvenile idiopathic arthritis. J Immunol 2004, 172:6435-6443.
41. + regulatory T cells. J Exp Med 2001, 194: 847-853.
42. Radstake TR, Van Der Voort R, Ten Brummelhuis M, De Waal Malefijt M, Schreurs W, Looman M, Sloetjes A, Figdor CG, Van Den Berg WB, Barrera P, et al.: Increased expression of CCL18, CCL19, and CCL17 by dendritic cells from patients with rheumatoid arthritis and regulation by Fc gamma receptors. Ann Rheum Dis 2004.
43. Suzuki N, Nakajima A, Yoshino S, Matsushima K, Yagita H, Okumura K: Selective accumulation of CCR5+ T lymphocytes into inflamed joints of rheumatoid arthritis. Int Immunol 1999, 11:553-559.
44. Buckley CD, Amft N, Bradfield PF, Pilling D, Ross E, Arenzana-Seisdedos F, Amara A, Curnow SJ, Lord JM, Scheel-Toellner D, et al.: Persistent induction of the chemokine receptor CXCR4 by TGF-beta 1 on synovial T cells contributes to their accumulation within the rheumatoid synovium. J Immunol 2000, 165: 3423-3429.
45. Nanki T, Hayashida K, El-Gabalawy HS, Suson S, Shi K, Girschick HJ, Yavuz S, Lipsky PE: Stromal cell-derived factor-1-CXC chemokine receptor 4 interactions play a central role in CD4+ T cell accumulation in rheumatoid arthritis synovium. J Immunol 2000, 165:6590-6598.
46. Zou L, Barnett B, Safah H, Larussa VF, Evdemon-Hogan M, Mottram P, Wei S, David O, Curiel TJ, Zou W: Bone marrow is a reservoir for CD4+CD25+ regulatory T cells that traffic through CXCL12/CXCR4 signals. Cancer Res 2004, 64:8451-8455.
47. Belkaid Y, Piccirillo CA, Mendez S, Shevach EM, Sacks DL: CD4+CD25+ regulatory T cells control Leishmania major persistence and immunity. Nature 2002, 420:502-507.
48. Montagnoli C, Bacci A, Bozza S, Gaziano R, Mosci P, Sharpe AH, Romani L: B7/CD28-dependent CD4+CD25+ regulatory T cells are essential components of the memory-protective immunity to Candida albicans. J Immunol 2002, 169:6298-6308.
49. Petersen J, Andersen V, Ingemann-Hansen T, Halkjaer-Kristensen J, Wiik A, Thyssen H: Synovial fluid and blood monocyte influence on lymphocyte proliferation in rheumatoid arthritis and traumatic synovitis. Scand J Rheumatol 1983, 12:299-304.
50. Black AP, Bhayani H, Ryder CA, Gardner-Medwin JM, Southwood TR: T-cell activation without proliferation in juvenile idiopathic arthritis. Arthritis Res 2002, 4:177-183.
51. Salmon M, Scheel-Toellner D, Huissoon AP, Pilling D, Shamsadeen N, Hyde H, D'Angeac AD, Bacon PA, Emery P, Akbar AN: Inhibition of T cell apoptosis in the rheumatoid synovium. J Clin Invest 1997, 99:439-446.
52. van Amelsfort JM, Noordegraaf M, Bijlsma JWJ, Taams LS, Lafeber FPJG: Influence of the inflammatory milieu on the suppressive function of CD4+CD25+ T cells in rheumatoid arthritis. Arthritis Rheum 2004, 50:S526.
53. Hirano T, Matsuda T, Turner M, Miyasaka N, Buchan G, Tang B, Sato K, Shimizu M, Maini R, Feldmann M, et al.: Excessive production of interleukin 6/B cell stimulatory factor- 2 in rheumatoid arthritis. Eur J Immunol 1988, 18:1797-1801.
54. Pasare C, Medzhitov R: Toll pathway-dependent blockade of CD4+CD25+ T cell-mediated suppression by dendritic cells. Science 2003, 299:1033-1036.
55. Morgan ME, Sutmuller RP, Witteveen HJ, van Duivenvoorde LM, Zanelli E, Melief CJ, Snijders A, Offringa R, de Vries RR, Toes RE: CD25+ cell depletion hastens the onset of severe disease in collagen-induced arthritis. Arthritis Rheum 2003, 48:1452-1460.
56. Fukaura H, Kent SC, Pietrusewicz MJ, Khoury SJ, Weiner HL, Hafler DA: Induction of circulating myelin basic protein and proteolipid protein-specific transforming growth factor-beta1-secreting Th3 T cells by oral administration of myelin in multiple sclerosis patients. J Clin Invest 1996, 98:70-77.
57. Groux H, Bigler M, de Vries JE, Roncarolo MG: Interleukin-10 induces a long-term antigen-specific anergic state in human CD4+ T cells. J Exp Med 1996, 184:19-29.
58. + T-cell subset inhibits antigen-specific T-cell responses and prevents colitis. Nature 1997, 389: 737-742.
59. Asseman C, Powrie F: Interleukin 10 is a growth factor for a population of regulatory T cells. Gut 1998, 42:157-158.
60. Cottrez F, Hurst SD, Coffman RL, Groux H: T regulatory cells 1 inhibit a Th2-specific response in vivo. J Immunol 2000, 165: 4848-4853.
61. + T cells with regulatory properties by repetitive stimulation with allogeneic immature human dendritic cells. J Exp Med 2000, 192:1213-1222.